Literature DB >> 7088231

Hypouricemia due to renal urate wasting. Two types of tubular transport defect.

Y Tofuku, M Kuroda, R Takeda.   

Abstract

We present 2 patients associated with hypouricemia. Serum uric acid levels were 1.6 and 1.3 mg/100 ml, and the ratios of urate clearance to creatinine clearance were 34.1 and 39.4%, respectively, while glomerular filtration rates (GFR) were normal. In the pyrazinamide (PZA) suppression test these 2 patients showed a different response of urate excretion. In the first patient urate excretion showed only a slight decrease following PZA. The load of benzbromarone did not increase urate excretion significantly. This patient is considered to have a defect of urate reabsorption in the proximal tubule, resulting in renal uricosuria. The second patient, on the contrary, showed nearly complete suppression of urate excretion after PZA. Uricosuric response to benzbromarone was far less than in the normal subjects. The suppression rate of urate excretion following PZA in benzbromarone-induced uricosuria was similar to the value of the normals. These results suggest that the latter had a defect of postsecretory reabsorption of urate in the tubule.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7088231     DOI: 10.1159/000182430

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  3 in total

1.  Acute renal failure due to uric acid nephropathy in a patient with renal hypouricemia.

Authors:  C M Erley; R R Hirschberg; W Hoefer; K Schaefer
Journal:  Klin Wochenschr       Date:  1989-03-01

2.  Effects of pyrazinamide, probenecid, and benzbromarone on renal excretion of oxypurinol.

Authors:  T Yamamoto; Y Moriwaki; S Takahashi; M Suda; K Higashino
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

3.  Familial hypouricaemia due to an isolated tubular defect of urate reabsorption.

Authors:  D Barajas de Frutos; B Bravo Mancheño; N Palomino Urda; J Pedrero Vera
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.